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Stress exposure is associated with the pathogenesis
of psychiatric disorders, including post-traumatic
stress disorder (PTSD) andmajor depressive disorder
(MDD). Here, we show in rodents that chronic stress
exposure rapidly and transiently elevates hippocam-
pal expression of Kruppel-like factor 9 (Klf9). Induc-
ible genetic silencing of Klf9 expression in excitatory
forebrain neurons in adulthood prior to, but not after,
onset of stressor prevented chronic restraint stress
(CRS)-induced potentiation of contextual fear acqui-
sition in female mice and chronic corticosterone
(CORT) exposure-induced fear generalization in
male mice. Klf9 silencing prevented chronic CORT
and CRS induced enlargement of dendritic spines in
the ventral hippocampus of male and female mice,
respectively. KLF9 mRNA density was increased in
the anterior dentate gyrus of women, but not men,
with more severe recent stressful life events and
increased mortality. Thus, Klf9 functions as a stress-
responsive transcription factor that mediates circuit
and behavioral resilience in a sex-specific manner.
INTRODUCTION
It is widely recognized that post-traumatic stress disorder
(PTSD) and major depressive disorder (MDD) arise from interac-
tions between environmental factors such as stressful, traumatic
life events and genetic risk factors (Besnard and Sahay, 2016;
Caspi et al., 2010; Caspi and Moffitt, 2006; Liberzon and Abel-
son, 2016; Shin and Liberzon, 2010; Smoller, 2016). Further-Cell
This is an open access article undmore, the incidence of stress-related psychopathologies
including MDD and PTSD is higher in women than in men (Has-
kell et al., 2010; Kessler et al., 1993, 2005; Kornstein et al., 2000).
Traumatic and stressful life events activate the hypothalamic-pi-
tuitary axis and trigger release of nuclear stress hormones and
glucocorticoids or recruit other physiological neuropeptide ef-
fectors (de Kloet et al., 2005) that modify neural circuits (McEwen
et al., 2016). Sustained elevation of glucocorticoids or prolonged
exposure to restraint stress is thought to induce maladaptive re-
modeling in the hippocampus (and other brain regions) and,
consequently, to impair contextual fear memory processing
and regulation of the hypothalamic-pituitary axis (HPA). At a
neuronal level, there is growing appreciation that dendritic
spines in different cell types respond differentially to chronic
stressors (Gourley et al., 2013; Liston and Gan, 2011; Sousa
et al., 2000; Yau et al., 2016). Glucocorticoids increase dendritic
spine size on shorter timescales and may increase or decrease
dendritic spine density depending on duration of exposure and
cell type (Liston et al., 2013; Liston and Gan, 2011; Russo
et al., 2016). Social defeat stress, on the other hand, increases
the number of stubby excitatory spines (Christoffel et al.,
2011). Together, these observations suggest that chronic
stressors signal to the cytoskeleton, via the nucleus or non-ge-
nomically, to modify dendritic spines. However, despite ad-
vances in identifying transcription factors that sense chronic
stress signals to orchestrate changes in excitability (Gray et al.,
2017; Han and Nestler, 2017; Harris et al., 2015), we know
remarkably less about stress-responsive transcription factors
that regulate dendritic spine remodeling in the hippocampus
(Mucha et al., 2011; Son et al., 2012).
Previous work has suggested that Kruppel-like factor 9 (Klf9) is
a negative transcriptional regulator of dendritic spines (McAvoy
et al., 2016) in stress-naive mice and is a primary transcriptional
target of glucocorticoids (Bagamasbad et al., 2012; Bonett et al.,Reports 23, 3183–3196, June 12, 2018 ª 2018 The Author(s). 3183
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
2009; Datson et al., 2011). Acute, but not chronic, corticosterone
administration elevates Klf9 expression in the hippocampus of
malemice (Carter et al., 2013) and drives glucocorticoid receptor
occupancy at glucocorticoid response elements within the Klf9
promoter in dentate gyrus (DG) of male rats (Bagamasbad
et al., 2012). Consistent with these findings, KLF9 expression
is upregulated in the DG of individuals with MDD (Duric et al.,
2010). These observations suggest that Klf9 may be a stress-
sensitive factor that constrains maladaptive dendritic spine re-
modeling in the hippocampus and fear responses.
Here we show in rodents that acute restraint stress, but not
chronic restraint stress (CRS), increased expression of Klf9 in
hippocampus. To determine whether CRS- and corticosterone
(CORT)-induced transient Klf9 upregulation in the hippocampus
is adaptive or maladaptive, we genetically engineered mice in
which we could inducibly silence Klf9 expression in excitatory
forebrain neurons. We found that inducible genetic silencing of
Klf9 in excitatory forebrain neurons of stress-naive adult male
or female mice did not affect contextual fear processing at base-
line. However, Klf9 silencing prevented CRS-induced potentia-
tion of contextual fear acquisition in female mice and chronic
CORT exposure-induced generalization of fear in male mice.
Interestingly, these protective effects were seen only when Klf9
was silenced prior to, but not after, the onset of the stressor.
At a circuit level, we found that both chronic CORT and CRS
induced enlargement of dendritic spines in the ventral hippo-
campus in males and females, respectively, and that silencing
of Klf9 expression prevented these alterations. Analysis of hu-
man postmortem hippocampal tissue revealed increased KLF9
mRNA density in the anterior DG of women, but not men, with
more severe recent stressful life events and increased mortality
(suicide). Together, these observations implicate Klf9 as a
stress-responsive transcription factor and demonstrate that tar-
geting Klf9 is sufficient to confer resilience to chronic stress-
induced enlargement of dendritic spines in ventral hippocampus
and maladaptive fear responses in a sex-specific manner.
RESULTS
CRS Decreases Klf9 Expression in Forebrain Circuits
Studies in rodents and Xenopus suggest a role for acute stress
(glucocorticoid exposure or handling stress) in elevating Klf9
expression levels (Bagamasbad et al., 2012; Bonett et al.,
2009; Datson et al., 2011). Furthermore, preliminary microarray
analysis of postmortem hippocampal tissue of MDD patients re-
ported elevated KLF9 expression in the DG, although character-
ization of KLF9 expression as a function of gender, stress history
of subjects, and anterior-posterior axis of DG was not assessed
(Duric et al., 2010). In order to gain further insights into the rela-
tionship between stress (acute versus chronic) and Klf9 expres-
sion, we analyzed the pattern of Klf9 expression in mice sub-
jected to acute restraint stress (6 hr, 1 day) and CRS (6 hr,
10 days). Upon completion of the restraint stress procedure,
mice were sacrificed and the brains were processed for in situ
hybridization studies using a riboprobe specific for Klf9 (Scobie
et al., 2009). We found that acute restraint stress, like acute
glucocorticoid exposure, increased Klf9 expression levels in
ventral DG and ventral CA1, motor cortex and cerebellum (Fig-3184 Cell Reports 23, 3183–3196, June 12, 2018ures 1A and 1B). In contrast, Klf9 expression was not elevated
in these areas following CRS (Figures 1C and 1D). Interestingly,
chronic CORT treatment, unlike acute CORT treatment, does not
elevate Klf9 expression in the hippocampus (Carter et al., 2013).
A Genetic System to Inducibly and Reversibly Silence
Klf9 Expression in Excitatory Forebrain Neurons
To determine whether the transient Klf9 upregulation seen
following onset of stressor is adaptive or maladaptive, we engi-
neered mice in which we can inducibly silence Klf9 expression
in distinct cell types. Klf9 is expressed in neuronal and non-
neuronal cell types (Carter et al., 2013; Dugas et al., 2012;
McAvoy et al., 2016; Scobie et al., 2009), and we chose to target
Klf9 expression in excitatory neurons, as the glucocorticoid re-
ceptor is required in excitatory forebrain neurons for modulating
fear responses (Hartmann et al., 2017). Toward this goal, we
bred mice that we engineered to carry a tetracycline response
element (Tre) knocked in upstream of the Klf9 gene (Tre-Klf9)
(McAvoy et al., 2016) withmice carrying a tetracycline-controlled
transcriptional silencer (tTS) transgene under the control of a
CamKIIa promoter fragment (Richardson-Jones et al., 2011)
(Figure 2A). Doxycycline (DOX) in the diet (Figure 2B) or with-
drawal (Figure 2C) prevents or triggers the silencing of the
gene of interest (Klf9), respectively, in bigenic mice carrying
two copies of the Tre-Klf9 allele and one copy of the tTS trans-
gene (referred to as tTS:Tre-Klf9). We first analyzed Klf9 expres-
sion in tTS:Tre-Klf9 mice and control littermates lacking the tTS
transgene (Tre-Klf9) that were raised without DOX (OFF) and
perfused at 10, 22, and 50 days following birth (Figure 2D). In
situ hybridization analysis revealed that CamKIIa-tTS potently
suppressesKlf9 expression in DG and other hippocampal subre-
gions (Figures 2E and 2F; data not shown). We then asked
whether we could use our bigenic system to inducibly and
reversibly silence Klf9 expression in the forebrain. We generated
four groups of adult tTS:Tre-Klf9mice raised on DOX in diet until
2 months of age, following which two groupsweremaintained on
DOX (ON) and two groups were taken off DOX (OFF) for 3 weeks
(0 week time point) (Figure 2G). One of the ON groups was then
taken off DOX to assess inducible silencing (ON-ON-OFF) and
the other one maintained on DOX to permit assessment of leak-
iness (ON-ON-ON). One of the OFF groups was brought back on
DOX to determine if silencing was reversible (ON-OFF-ON), while
the other group remained off DOX to permit examination of sus-
tained inducible silencing (ON-OFF-OFF). We then examined
Klf9 expression levels in the hippocampus, cortex (motor, piri-
form, and retrosplenial), and cerebellum (Figure 2G). Our results
suggest that DOX administration conferred inducible silencing of
Klf9 expression in tTS:Tre-Klf9 mice. Specifically, ON-ON-OFF
and ON-OFF-OFF mice showed significantly lower Klf9 expres-
sion in DG, CA3 and CA1 compared with ON-ON-ON and ON-
OFF-ON mice (Figures 2H and 2I). Furthermore, silencing of
Klf9 expression was reversible as evidenced in the ON-OFF-
ON and ON-ON-ON groups that exhibited similar levels of Klf9
expression (Figures 2H and 2I). These effects were detected in
the hippocampus and not observed in the cortices examined
and cerebellum (Figures 2J and 2K). Together, these findings
demonstrate the utility of tTS:Tre-Klf9 mice in inducible and
































































































































Figure 1. Chronic Restraint Stress Decreases Klf9 Expression in
Forebrain Circuits
(A) In situ hybridization using specific riboprobes to assess Kruppel-like factor
9 (Klf9) mRNA expression in the hippocampus of mice acutely restrained for
6 hr (right) and home cage controls (left). Representative images for five in-
dependent animals per group. Scale bar: 200 mm.
(B) Quantifications of Klf9 mRNA expression (percentage background) across
the hippocampus, cortical areas, and cerebellum. Data (mean ± SEM; n = 5
and 5 mice per group) were analyzed using unpaired two-tailed Student’s t
test; *p < 0.05, acute stress versus controls.
(C) In situ hybridization of Klf9 mRNA expression in the hippocampus of mice
chronically (10 days) restrained for 6 hr (right) and home cage controls (left).
Representative images for five and three independent animals per group.
Scale bar: 200 mm.
(D) Quantifications of Klf9mRNA expression (percentage background) across
the hippocampus, cortical areas, and cerebellum. Data (mean ± SEM; n = 5CRS and Chronic CORT Treatment Differentially Affect
Fear Responses in Male and Female Mice
Growing evidence suggests that male and female mice respond
differentially to stressors (Gray et al., 2017). Therefore, we asked
whether chronic CORT and CRS differentially affect contextual
fear memory in male and female tTS:Tre-Klf9 mice with intact
levels of Klf9 expression (maintained on DOX) (Figure S1).
Upon exposure to 5 weeks of 35 mg/mL CORT, male tTS:Tre-
Klf9mice (Figure S1A) showed normal contextual fear condition-
ing (CFC) in context A (Figures S1B and S1D) but increased fear
generalization in a distinct context C (Figure S1E). Conversely,
female tTS:Tre-Klf9 mice (Figure S1A) showed no alteration in
contextual fear learning and generalization in response to
35 mg/mL CORT treatment (Figures S1F and S1G). These results
are in line with recent findings suggesting that chronic CORT
exposure has limited effects on behavioral emotionality in female
mice (Mekiri et al., 2017). Furthermore, male but not female mice
exhibited CORT-dependent weight gain (data not shown). In
contrast to CORT, 2 weeks of CRS potentiated contextual fear
acquisition in female but not male tTS:Tre-Klf9 mice (Figures
S1H–S1N).
Inducible Silencing of Klf9 Expression in Forebrain
Excitatory Neurons Prevents Chronic CORT-Induced
Overgeneralization of Contextual Fear in Male Mice
We next sought to leverage the tTS:Tre-Klf9 mice to causally
ascertain whether silencing Klf9 expression protects against
chronic CORT-induced fear responses in male mice (Fig-
ure 3A). Four groups of male tTS:Tre-Klf9 mice were main-
tained on DOX until 2 months of age. Two groups were then
kept on DOX and two groups were switched off DOX for
3 weeks, following which each pair of ON and OFF DOX
groups was exposed to either chronic CORT (stress condition)
or b-cyclodextrin vehicle in drinking water while remaining on
or off DOX, respectively (non-stress condition) (Figure 3A). We
examined CFC in context A, discrimination between the
training context A and a safe, similar context B, and general-
ization in a distinct context C 5 weeks after the initiation of
CORT or b-cyclodextrin treatment (Figure 3B). Unlike Klf9-
null mice that lack Klf9 in all cell types and throughout life
(Scobie et al., 2009), stress-naive mice in which Klf9 expres-
sion was acutely silenced in excitatory forebrain neurons did
not exhibit impairments in CFC, discrimination, or generaliza-
tion in the absence of stress (Figures 3C–3K). In contrast,
inducible Klf9 silencing in excitatory forebrain neurons pre-
vented CORT-induced generalization of fear in context C
(Figures 3C–3K). Specifically, CORT-treated mice showed
enhanced levels of freezing compared with vehicle-treated
mice in the safe, distinct context C (Figure 3J). This effect
was completely reversed in CORT-treated mice, in which
Klf9 expression was silenced in excitatory hippocampal neu-
rons (OFF DOX) (Figure 3J).
Next, we asked whether silencing Klf9 expression following
acute CORT-dependent elevation in Klf9 expression preventsand 3 mice per group) were analyzed using unpaired two-tailed Student’s
t test.
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Figure 2. A Genetic System to Inducibly and Reversibly Silence Klf9 Expression in Excitatory Forebrain Neurons
(A–C) Schematic representation of mice homozygous for Tre-Klf9 and expressing tTS in the forebrain under the control of a CamKIIa promoter (A). This genetic
system is responsive to doxycycline, which is provided in the animal’s diet. Doxycycline diet (B) or withdrawal (C) prevents or triggers the silencing of Klf9.
(D) Schematic representation for Tre-Klf9/CamKIIa-tTSmice (referred to as tTS:Tre-Klf9) and Tre-Klf9 (no CamKIIa-tTS) mice raisedwithout doxycycline (OFF) for
10, 22, and 50 postnatal days.
(E) In situ hybridization of Klf9mRNA expression in the dentate gyrus (DG) of Tre-Klf9 (left) and tTS:Tre-Klf9 (right). Representative images for three independent
animals per group. Scale bar: 200 mm.
(F) Quantifications of Klf9mRNA expression (percentage background) in the DG. Data (mean ± SEM; n = 3, 3, 3, 3, 3, and 3 mice per group) were analyzed using
mixed-factor two-way ANOVA: time F(2,12) = 8.33, p < 0.01; doxycycline F(1,12) = 152.12, p < 0.001; interaction F(2,12) = 37.18, p < 0.001. **p < 0.01 and ***p < 0.001,
tTS:Tre-Klf9 versus Tre-Klf9.
(G) Schematic representation of tTS:Tre-Klf9 mice with different doxycycline diet schedules.
(H) In situ hybridization of Klf9mRNA expression in the DG of tTS:Tre-Klf9 with different doxycycline diet schedules. Representative images for six independent
animals per group. Scale bar: 200 mm.
(I–K) Quantifications of Klf9 mRNA expression (percentage background) in the hippocampus (I), cortices (J), and cerebellum (K). Data (mean ± SEM; n = 6, 6, 6,
and 6 mice per group) were analyzed using one-way ANOVA followed by Tukey’s multiple-comparisons post hoc test. *p < 0.05 and **p < 0.01, OFF DOX versus
ON DOX.CORT-induced fear overgeneralization inmalemice (Figure S2A).
Tre-Klf9 and tTS:Tre-Klf9 male mice were maintained on DOX
until 2 months of age, and then both groups were exposed to
CORT in drinking water for 1 week to induce elevation in Klf9
expression. After 1 week of CORT treatment and with CORT
on board, we silenced Klf9 expression by removal of DOX for3186 Cell Reports 23, 3183–3196, June 12, 20184.5 weeks and tested the mice in CFC, context discrimination
and generalization assays (Figures S2B and S2C). Interestingly,
unlike mice in which Klf9 expression was silenced prior to
chronic CORT treatment (Figure 3), silencing Klf9 expression
following 1 week of CORT treatment did not prevent CORT-
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Figure 3. Inducible Silencing of Klf9 Expression in Forebrain Excitatory Neurons of Male Mice Prevents Chronic CORT-Induced Over-
generalization of Contextual Fear
(A) Schematic representation of tTS:Tre-Klf9 male mice with different doxycycline and corticosterone diet schedules.
(B) CFCDL procedure in which mice were trained to discriminate between a footshock delivered in context A and safe contexts B and C.
(C) Schematic representation of CFCDL timeline consisting of 3 days of training in context A and discrimination tests on day 4.
(D) Freezing behavior on day 1. Data (mean ± SEM; n = 11, 11, 12, and 11 mice per group) were analyzed using mixed-factor two-way ANOVA: corticosterone
F(1,41) = 5.32, p < 0.05; doxycycline F(1,41) = 3.71, not significant (NS); interaction F(1,41) = 2.96, NS.
(E) Freezing behavior on day 2. Data (mean ± SEM; n = 11, 11, 12, and 11 mice per group) were analyzed using mixed-factor two-way ANOVA: corticosterone
F(1,41) = 2.65, NS; doxycycline F(1,41) = 5.63, p < 0.05; interaction F(1,41) = 0.00, NS.
(F) Freezing behavior on day 3. Data (mean ± SEM; n = 11, 11, 12, and 11 mice per group) were analyzed using mixed-factor two-way ANOVA: corticosterone
F(1,41) = 0.02, NS; doxycycline F(1,41) = 3.69, NS; interaction F(1,41) = 0.03, NS.
(G) Freezing behavior on day 4A. Data (mean ± SEM; n = 11, 11, 12, and 11 mice per group) were analyzed using mixed-factor two-way ANOVA: corticosterone
F(1,41) = 0.29, NS; doxycycline F(1,41) = 2.18, NS; interaction F(1,41) = 0.00, NS.
(H) Freezing behavior on day 4B. Data (mean ± SEM; n = 11, 11, 12, and 11 mice per group) were analyzed using mixed-factor two-way ANOVA: corticosterone
F(1,41) = 0.88, NS; doxycycline F(1,41) = 8.53, p < 0.01; interaction F(1,41) = 1.29, NS.
(I) Discrimination ratio calculated for contexts A and B. Data (mean ± SEM; n = 11, 11, 12, and 11 mice per group) were analyzed using mixed-factor two-way
ANOVA: corticosterone F(1,41) = 2.49, NS; doxycycline F(1,41) = 11.67, p < 0.01; interaction F(1,41) = p < 0.05; **p < 0.01, ON CORT OFF DOX versus ON DOX.
(J) Freezing behavior on day 4C. Data (mean ± SEM; n = 11, 11, 12, and 11 mice per group) were analyzed using mixed-factor two-way ANOVA: corticosterone
F(1,41) = 10.34, p < 0.01; doxycycline F(1,41) = 6.88, p < 0.05; interaction F(1,41) = 2.67, NS.
(K) Discrimination ratio calculated for contexts A and C. Data (mean ± SEM; n = 11, 11, 12, and 11 mice per group) were analyzed using mixed-factor two-way
ANOVA: corticosterone F(1,41) = 12.52, p < 0.01; doxycycline F(1,41) = 6.01, p < 0.05; interaction F(1,41) = 2.44, NS.
See also Figures S1 and S2.
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Collectively, these results indicate that decreasing Klf9
expression in excitatory forebrain neurons prevents CORT-
induced fear overgeneralization in male mice. Furthermore,
Klf9 silencing in excitatory forebrain neurons after the acute
phase of CORT exposure is not sufficient to prevent CORT-
induced fear overgeneralization in male mice.
Inducible Silencing of Klf9 Expression in Forebrain
Excitatory Neurons Prevents Chronic CORT-Induced
Enlargement in Dendritic Spines in Ventral DG in Male
Mice
Because both stress and Klf9 target dendritic spines, we next
examined whether Klf9 silencing could reverse CORT-induced
changes to hippocampal spine morphology. We thus examined
dendritic spines in DG and CA1 of dorsal and ventral hippocam-
pus in non-stressed and chronic CORT-treated triple transgenic
male mice tTS:Tre-Klf9:Thy1-GFP/+ in which the Thy-1 GFP
allele permits evaluation of dendritic spine structure and density
(Figures 4A and 4B). Silencing Klf9 expression increased den-
dritic spine density in dorsal and ventral DG, but not CA1, of
non-stressed mice (Figures 4C and 4E). Interestingly, and
consistent with previous reports (Sousa et al., 2000; Yau et al.,
2016), chronic CORT did not affect dendritic spine density in
DG and CA1 (Figures 4C–4F). However, analysis of dendritic
spine width revealed that CORT induced an enlargement of
spines in ventral DG and that Klf9 silencing reversed this spine
enlargement phenotype (Figure 4E). Together, these observa-
tions suggest that targeting CORT-induced increase in dendritic
spine width in ventral DG may represent a potential substrate for
preventing CORT-induced fear overgeneralization.
Inducible Silencing of Klf9 Expression in Forebrain
Excitatory Neurons Prevents CRS-Induced Potentiation
of Contextual Fear Acquisition in Female Mice
Our analysis of chronic stressors in male and female mice
revealed that CRS potentiates contextual fear acquisition in
female, but not male, mice (Figures S1K–S1N). Therefore, we
next asked whether inducible Klf9 silencing is protective against
the effects of another chronic stressor, CRS, on fear responses
in female tTS:Tre-Klf9 mice (Figure 5A). To this end, we used
four groups of female tTS:Tre-Klf9 that were maintained on
DOX until 2 months of age. We then took two groups off DOX
for 1 week prior to initiating CRS for one pair of ON and OFF
DOX groups for 14 days (stress condition) while the other pair
of ON and OFF DOX groups remained in the home cage (non-
stress condition) (Figure 5A). Ten days following cessation of
CRS, we examined CFC in context A and discrimination between
the training context A and a safe, similar context B (Figure 5B).
Klf9 silencing in forebrain excitatory neurons prevented CRS-
induced potentiation of contextual fear acquisition without
affecting fear responses in non-stressed mice (Figures 5C–5E).
Additionally, inducible Klf9 silencing in stressed and non-
stressed groups did not affect contextual fear discrimination as
assessed by measuring freezing levels in contexts A and B
(Figures 5F–5H).
Next, we asked whether silencing Klf9 expression following
acute restraint stress (rather than prior) protects against CRS-
induced potentiation of fear responses in female mice (Fig-3188 Cell Reports 23, 3183–3196, June 12, 2018ure S2G). Two groups of female Tre-Klf9 and tTS:Tre-Klf9 mice
were maintained on DOX until 2 months of age, and then both
groups were subjected to CRS for 10 days. Following cessation
of CRS, both groups were taken off DOX for 2 weeks and tested
in CFC, context discrimination, and generalization assays (Fig-
ures S2H and S2I). Unlike the mice in which Klf9 expression
was decreased prior to and during CRS (Figure 5), silencing
Klf9 expression following CRS did not reverse CRS-induced
potentiation of fear responses (Figures S2J–S2L).
Taken together with our studies using CORT, these results
suggest that decreasing Klf9 expression prior to (and during)
the onset of stressor protects against stress-induced maladap-
tive fear responses.
Inducible Silencing of Klf9 Expression in Forebrain
Excitatory Neurons Prevents CRS Enlargement in
Dendritic Spines in Ventral CA1 in Female Mice
We next sought to determine the effects of inducible Klf9
silencing on CRS-induced alterations in dendritic spines in DG
and CA1 using female triple transgenic tTS:Tre-Klf9:Thy1-GFP/
+ mice (Figure 6A). CRS and inducible Klf9 silencing did not
affect dendritic spine density in DG and CA1 (Figures 6B–6F).
Remarkably, CRS increased dendritic spine width in CA1, but
not DG, and this effect was completely reversed byKlf9 silencing
in ventral CA1 (Figure 6F). Furthermore, CRS failed to enlarge
dendritic spines in male triple transgenic tTS:Tre-Klf9:Thy1-
GFP/+ mice (Figure S3). These results suggest ventral CA1 as
a potential substrate for the protective effects of Klf9 silencing
on CRS-induced potentiation of contextual fear acquisition in
female mice.
Increased KLF9 Expression in the DG of Women with
MDD-Suicide and Recent History of Stressful Life
Events
A microarray analysis performed on postmortem hippocampal
tissue of individuals with MDD found KLF9 expression to be
elevated in the DG (Duric et al., 2010). However, the study did
not assess KLF9 expression in relation to recent or chronic
stress, sex, and subject treatment status. Moreover, KLF9
expression was not examined along the anterior-posterior axis
of DG. Approximately 40% of subjects with MDD had prescrip-
tions for antidepressants filled in the last month of life, and
compliance was unknown, but ongoing antidepressant treat-
ment could potentially affect KLF9 mRNA expression. To begin
to better understand how KLF9 expression is affected by recent
life event-related stress exposure and gender, we performed in
situ hybridization on postmortem hippocampus from 12 subjects
with untreated MDD, 10 of whom died by suicide, and 12 con-
trols with no history of neuropsychiatric disease or treatment
(Table S1). All subjects deceased suddenly without prolonged
agonal phase and had clear neuropathology and toxicology
exams. Diagnostic and Statistical Manual of Mental Disorders
(DSM) IV diagnosis was determined by validated psychological
autopsy using the Structured Clinical Interview for DSM (SCID)
I (Kelly andMann, 1996). Recent (last 3months) life event-related
stress was quantified using the St. Paul-Ramsey Life Experience
Scale. Given the role of the ventral (anterior in humans) hippo-
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Figure 4. Inducible Silencing ofKlf9 Expression in Forebrain Excitatory Neurons of MaleMice Prevents Chronic CORT-Induced Enlargement
in Dendritic Spines in Ventral DG
(A) Schematic representation of tTS:Tre-Klf9:Thy1-GFP/+ male mice with different doxycycline and corticosterone diet schedules.
(B) Maximum intensity projection confocal images of individual dendritic segments from the outer molecular layer in ventral DG. Representative images for four
independent animals per group. Scale bar: 2 mm.
(C) Spine density and width in dorsal DG (red box). Data (mean ± SEM; n = 4, 4, 4, and 4 mice per group) were analyzed using mixed-factor two-way ANOVA:
density: corticosterone F(1,12) = 0.34, NS; doxycycline F(1,12) = 11.0, p < 0.01; interaction F(1,12) = 0.02, NS; width: corticosterone F(1,12) = 4.56, NS; doxycycline
F(1,12) = 2.45, NS; interaction F(1,12) = 0.02, NS.
(D) Spine density and width in dorsal CA1 (red box). Data (mean ± SEM; n = 4, 4, 4, and 4 mice per group) were analyzed using mixed-factor two-way ANOVA:
density: corticosterone F(1,12) = 0.75, NS; doxycycline F(1,12) = 3.91, NS; interaction F(1,12) = 1.18, NS; width: corticosterone F(1,12) = 1.42, NS; doxycycline F(1,12) =
10.99, p < 0.01; interaction F(1,12) = 0.94, NS.
(E) Spine density and width in ventral DG (red box). Data (mean ± SEM; n = 4, 4, 4, and 4 mice per group) were analyzed using mixed-factor two-way ANOVA:
density: corticosterone F(1,12) = 2.78, NS; doxycycline F(1,12) = 4.97, p < 0.05; interaction F(1,12) = 0.01, NS; width: corticosterone F(1,12) = 17.59, p < 0.01;
doxycycline F(1,12) = 9.34, p < 0.01; interaction F(1,12) = 3.29, NS.
(F) Spine density and width in ventral CA1 (red box). Data (mean ± SEM; n = 4, 4, 4, and 4 mice per group) were analyzed using mixed-factor two-way ANOVA:
density: corticosterone F(1,12) = 0.07, NS; doxycycline F(1,12) = 3.99, NS; interaction F(1,12) = 0.41, NS; width: corticosterone F(1,12) = 0.01, NS; doxycycline F(1,12) =
3.97, NS; interaction F(1,12) = 2.55, NS.expression in the anterior hippocampal DG (Figures 7A and 7B,
red outline). Remarkably, we found that women, but not men,
with MDD showed increased levels of KLF9 expression in ante-
rior DG compared with controls (Figure 7C). In addition, a signif-
icant positive correlation between anterior DG KLF9 expressionand the severity of recent stressful life events was found in
women but not men (Figure 7D). Our results from this preliminary
sample suggest that stressful experiences may upregulate KLF9
expression in the DG in a gender-specific manner and possibly
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Figure 5. Inducible Silencing ofKlf9Expres-
sion in Forebrain Excitatory Neurons of
Female Mice Prevents CRS-Induced Poten-
tiation of Contextual Fear Acquisition
(A) Schematic representation of tTS:Tre-Klf9
female mice with different doxycycline diet
schedules and chronic restraint stress timeline.
(B) CFCDL procedure in which mice were trained
to discriminate between a footshock delivered in
context A and safe context B.
(C) Freezing behavior on day 1. Data (mean ±
SEM; n = 12, 11, 10, and 11 mice per group) were
analyzed using mixed-factor two-way ANOVA:
CRS F(1,40) = 0.13, NS; doxycycline F(1,40) = 0.97,
NS; interaction F(1,40) = 0.04, NS.
(D) Freezing behavior on day 2. Data (mean ±
SEM; n = 12, 11, 10, and 11 mice per group) were
analyzed using mixed-factor two-way ANOVA:
CRS F(1,40) = 0.49, NS; doxycycline F(1,40) = 0.28,
NS; interaction F(1,40) = 3.64, NS.
(E) Freezing behavior on day 3. Data (mean ± SEM;
n = 12, 11, 10, and 11 mice per group) were
analyzed using mixed-factor two-way ANOVA:
CRS F(1,40) = 1.62, NS; doxycycline F(1,40) = 9.35,
p < 0.01; interaction F(1,40) = 5.4, p < 0.05; *p < 0.05
and **p < 0.01, ON CORT ON DOX versus
OFF DOX.
(F) Freezing behavior on day 4A. Data (mean ±
SEM; n = 12, 11, 10, and 11 mice per group) were
analyzed using mixed-factor two-way ANOVA:
CRS F(1,40) = 0.01, NS; doxycycline F(1,40) = 6.29,
p < 0.05; interaction F(1,40) = 0.27, NS.
(G) Freezing behavior on day 4B. Data (mean ±
SEM; n = 12, 11, 10, and 11 mice per group) were
analyzed using mixed-factor two-way ANOVA:
CRS F(1,40) = 0.46, NS; doxycycline F(1,40) = 1.14,
NS; interaction F(1,40) = 2.56, NS.
(H) Discrimination ratio calculated for contexts A
and B. Data (mean ± SEM; n = 12, 11, 10, and
11 mice per group) were analyzed using mixed-
factor two-way ANOVA: CRS F(1,40) = 1.16, NS;
doxycycline F(1,40) = 0.03, NS; interaction F(1,40) =
1.99, NS.
See also Figures S1 and S2.DISCUSSION
Understanding how chronic stress engenders maladaptive fear
responses will edify treatments for stress-related psychopathol-
ogies such as PTSD and MDD. Essential to this challenge is
instantiation of the transcriptional and non-genomic mecha-
nisms that link physiological effectors of chronic stress with
changes in dendritic spines in brain regions such as the hippo-
campus. Our studies identify a role for Klf9 as one such mediator
whose expression is regulated by stress in both the rodent and
human hippocampus. Importantly, downregulation of Klf9 in
excitatory forebrain neurons prevents chronic stress-induced
enlargement of dendritic spines in the ventral hippocampus
and dysregulation of fear.
Our studies show that acute restraint stress, as well as acute
CORT treatment (Carter et al., 2013), elevates Klf9 expression
in the hippocampus. In contrast, CRS does not maintain the
elevation in Klf9 expression in principal cell populations of the3190 Cell Reports 23, 3183–3196, June 12, 2018hippocampus induced by the acute phase of stressor. The resto-
ration of Klf9 expression levels to baseline following the acute
phase of stressor may be mediated by glucocorticoid receptor
(GR) signaling (Bagamasbad et al., 2012; Bonett et al., 2009; Dat-
son et al., 2011) or other physiological regulators of Klf9 expres-
sion such as neural activity (Flavell et al., 2008; Lin et al., 2008;
Scobie et al., 2009), thyroid hormone (Denver et al., 1999), and
progesterone and estrogen (Knoedler and Denver, 2014). To
determine whether the transient Klf9 upregulation seen following
onset of stressor is adaptive or maladaptive, we generated mice
in which we could inducibly silence Klf9 expression in excitatory
forebrain neurons. Inducible Klf9 silencing in stress-naive mice
did not affect contextual fear acquisition or generalization. How-
ever, Klf9 silencing prior to and during chronic CORT treatment
or CRS prevented fear generalization in a neutral context or
potentiation of acquisition of contextual fear in male and female
mice. Importantly, silencing Klf9 following the onset of the
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Figure 6. Inducible Silencing of Klf9 Expression in Forebrain Excitatory Neurons of Female Mice Prevents CRS Enlargement in Dendritic
Spines in Ventral CA1
(A) Schematic representation of tTS:Tre-Klf9:Thy1-GFP/+ female mice with different doxycycline diet schedules and chronic restraint stress timeline.
(B) Maximum intensity projection confocal images of individual dendritic segments from the stratum radiatum in ventral CA1. Representative images for four
independent animals per group. Scale bar: 2 mm.
(C) Spine density and width in dorsal DG (red box). Data (mean ± SEM; n = 4, 3, 4, and 3 mice per group) were analyzed using mixed-factor two-way ANOVA:
density: CRS F(1,10) = 2.86, NS; doxycycline F(1,10) = 1.03, NS; interaction F(1,10) = 0.04, NS; width: CRS F(1,10) = 0.13, NS; doxycycline F(1,10) = 0.68, NS; interaction
F(1,10) = 0.6, NS.
(D) Spine density and width in dorsal CA1 (red box). Data (mean ± SEM; n = 4, 3, 4, and 3 mice per group) were analyzed using mixed-factor two-way ANOVA:
density: CRS F(1,10) = 0.87, NS; doxycycline F(1,10) = 0.15, NS; interaction F(1,10) = 0.08, NS; width: CRS F(1,10) = 21.42, p < 0.001; doxycycline F(1,10) = 0.82, NS;
interaction F(1,10) = 1.76, NS.
(E) Spine density and width in ventral DG (red box). Data (mean ± SEM; n = 4, 3, 4, and 3 mice per group) were analyzed using mixed-factor two-way ANOVA:
density: CRS F(1,10) = 0.19, NS; doxycycline F(1,10) = 0.02, NS; interaction F(1,10) = 1.85, NS; width: CRS F(1,10) = 1.16, NS; doxycycline F(1,10) = 1.88, NS; interaction
F(1,10) = 0.23, NS.
(F) Spine density and width in ventral CA1 (red box). Data (mean ± SEM; n = 4, 3, 4, and 3 mice per group) were analyzed using mixed-factor two-way ANOVA:
density: CRS F(1,10) = 9.19, p < 0.05; doxycycline F(1,10) = 2.08, NS; interaction F(1,10) = 4.6, NS; width: CRS F(1,9) = 11.88, p < 0.01; doxycycline F(1,9) = 0.87, NS;
interaction F(1,9) = 5.48, p < 0.05; *p < 0.05 and **p < 0.01, ON CORT ON DOX versus OFF CORT ON DOX.
See also Figure S3.contextual fear generalization and acquisition inmale and female
mice, respectively. These data suggest that elevation of Klf9
levels in response to acute stressmay represent a potential path-
ogenic mechanism that produces lasting mal-adaptationsaltering contextual fear memory processing. In this regard, it is
noteworthy that Klf9 has a Sin3A interaction domain and can re-
cruit the mSin3A-corepressor complex associated with histone
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Figure 7. Increased KLF9 Expression in the DG of Women with
Recent History of Stressful Life Events
(A and B) Post mortem in situ hybridization using specific riboprobes to assess
KLF9mRNA expression in the anterior DG (red outline) of male (A) and female
(B) human subjects with recent history of stressful life events and major
depressive disorder (MDD). Representative images for six, six, five, and five
independent subjects per group. Scale bar: 50 mm.
(C) Quantifications of KLF9mRNA expression (percentage background) in the
anterior DG of male and female subjects. Data (mean ± SEM; n = 6 and 6
subjects per group) were analyzed using unpaired two-tailed Student’s t test.
Data (mean ± SEM; n = 5 and 5 subjects per group) were analyzed using un-
paired two-tailed Student’s t test; *p < 0.05, MDD versus controls.
(D) Quantifications of KLF9 mRNA expression (percentage background) in
the anterior DG correlated with the severity of recent stressful life events. Data
(n = 10 and 12 subjects per group). Note the significant positive correlation
between the KLF9 mRNA levels and the severity of recent stressful life events
in female (r2 = 0.818, p = 0.0003) but not male (r2 = 0.095, p = 0.328) subjects.
See also Table S1.et al., 2011). We hypothesize that transient upregulation of Klf9
expression by acute stress promotes long-lasting stress-
induced mal-adaptations through chromatin remodeling.
Because of the well-characterized role of the hippocampus in
contextual fear memory processing (Fanselow and Dong, 2010;
Maren et al., 2013; Strange et al., 2014; Tonegawa et al., 2015),
we analyzed dendritic spines in DG and CA1 subregions of dor-
sal and ventral hippocampus. Our studies identify vDG and
ventral CA1 (vCA1) as two putative loci of vulnerability to chronic
CORT and CRS in male and female mice, respectively. Both of
these subregions exhibited chronic stress-induced enlargement3192 Cell Reports 23, 3183–3196, June 12, 2018of dendritic spines, and silencing of Klf9 expression prevented
these alterations. In addition, we found that CRS induced
opposing effects on spine width in the vCA1 of male (decreased
spine width) and female (increased spine width) mice. This
observation resonates with a previous study showing how the
same stressful experience engenders opposing structural
changes in hippocampus of male and female mice (Shors
et al., 2001).
Howmight enlarged dendritic spines in these regions promote
maladaptive fear responses? One hypothesis is that CRS-
induced enlarged spines are inefficient (A.B. and A.S., unpub-
lished data) and disruption of encoding in ventral DG (vDG)
and vCA1 (Bagot et al., 2015) impairs hippocampal dependent
regulation of amygdala, prefrontal cortex, and nucleus accum-
bens (Ciocchi et al., 2015; Guo et al., 2018; Xu et al., 2016) to
gate stress-dependent aberrations in fear responses.
Klf9’s primary role is to constrain neuronal connectivity, as
exemplified in studies showing that acute overexpression of
Klf9 negatively regulates dendritic spine number (McAvoy
et al., 2016) and neurite growth (Moore et al., 2009, 2011). How
then do these functions of Klf9 explain the reversal in stress-
induced dendritic spine enlargement following Klf9 silencing?
Our data lead us to propose that Klf9 upregulation exerts
different biological effects on dendritic spines in stress-naive
mice and under conditions of stress exposure, a hypothesis
that remains to be tested. Klf9 is both an activator and a
repressor of transcription (Moore et al., 2011) and may be regu-
lated in different ways in naive mice and under conditions of
stress exposure. It is plausible that under conditions of stress
exposure, but not in stress-naivemice,Klf9 silencing suppresses
availability of factors that are recruited by chronic stress for spine
enlargement. These factors could be cytoskeletal molecules,
cell-surface receptors, or components of endocytic machinery
that facilitate dendritic spine growth.
Our human postmortem hippocampal tissue analysis uncov-
ered elevated levels of KLF9 mRNA expression in women but
not men with MDD-suicide and a positive correlation with
severity of recent stressful life events in women but not men.
These data suggest that elevation in KLF9 levels may represent
a potential pathogenic mechanism of MDD and/or suicide. By
integrating neural activity, sex, and stress hormones, Klf9 may
permit stress-induced adaptations in a sex-specificmanner. Up-
regulation of KLF9 expression levels may render threat-process-
ing circuits inefficient in calibrating fear responses. Further
studies are needed to determine if genetic mutations in the hu-
man population that impair KLF9 downregulation in response
to stress confer vulnerability to MDD and PTSD.EXPERIMENTAL PROCEDURES
Animal Studies
Animal Care
Male and female mice were housed four per cage in a 12 hr (7 a.m. to 7 p.m.)
light/dark colony room at 22C–24C with ad libitum access to food and
water. Behavioral experiments took place between 8 a.m. and 6 p.m. All
animals were handled and experiments were conducted in accordance with
procedures approved by the Institutional Animal Care and Use Committee at
the Massachusetts General Hospital and Boston University in accordance
with NIH guidelines.
Mouse Lines
Inducible and reversible silencing of Klf9 in forebrain excitatory neurons was
achieved by generating a bigenic tTS:Tre-Klf9 mouse line resulting from
breeding Tre-Klf9 mouse line (McAvoy et al., 2016) with CamKIIa-tTS line
(Richardson-Jones et al., 2011). This mouse line was homozygous for the
tetO insertion (Tre-Klf9/Tre-Klf9), had one copy of CamKIIa-tTS, and was fed
DOX ad libitum throughout life to allow the expression of endogenous Klf9 in
forebrain excitatory neurons.
Spine analyses was carried out by generating a trigenic mouse line resulting
from breeding tTS:Tre-Klf9 mouse line with Thy1-GFP (M Line) mice (Feng
et al., 2000), which were purchased from The Jackson Laboratory (strain
007788) and were maintained by crossing with homozygous Tre-Klf9. Tail
DNA from all offspring was genotyped by PCR to detect the presence of
each transgene separately. All experiments were conducted with 8- to
17-week-old mice (unless indicated otherwise).
Drugs
CORT was prepared as previously described (David et al., 2009). Specifically,
35 mg/mL (equivalent to 5 mg/kg/day) CORT (27840; Sigma-Aldrich, St. Louis,
MO, USA) was dissolved in 0.45% 2-hydroxypropyl cyclodextrin (332593;
Sigma-Aldrich) and delivered in lightproof bottles, available ad libitum in drink-
ing water. Control mice received 0.45% b-cyclodextrin in drinking water
(C4767; Sigma-Aldrich). DOX was provided in chow containing 200 mg/kg
DOX (S3888; Bioserv, Flemington, NJ, USA) fed ad libitum throughout life.
Control chow (S4207; Bioserv) was used when DOX was withdrawn from the
diet.
Acute and CRS
Acute restraint stress consisted in 6 hr of complete immobilization using
disposable mouse DecapiCone restrainers (DC M200; Braintree Scientific,
Braintree, MA, USA). CRS consisted of 6 hrs of complete immobilization using
disposable mouse DecapiCone restrainers each day for 14 consecutive days
before behavioral testing.
In Situ Hybridization
In situ hybridization (ISH) was performed using Klf9-specific riboprobes as
previously described (McAvoy et al., 2016) using dioxygenin-labeled ribop-
robes on 35 mm cryosections generated from perfused tissue. Premixed
RNA labeling nucleotide mixes containing digoxigenin-labeled UTP (Roche
Molecular Biochemicals) were used to generate RNA riboprobes. Ribop-
robes were purified on G-50 Microspin columns (GE Healthcare). Probe
concentration was confirmed by NanoDrop prior to the addition of form-
amide. Briefly, sections were mounted on charged glass (Superfrost Plus)
slides and postfixed for in 4% paraformaldehyde (PFA). Sections were
then washed in DEPC-treated PBS, treated with Proteinase K (40 mg/mL
final), washed again in DEPC-treated PBS, and then acetylated. Following
prehybridization, sections were incubated with riboprobe overnight at 58
and washed in decreasing concentrations of saline sodium citrate (SSC)
buffer, and immunological detection was carried out with anti-dioxygenin
antibody conjugated with alkaline phosphatase (Roche). Color reaction
was carried out with nitro blue tetrazolium (NBT)/5-bromo-4-chloro-3-in-
dolyl-phosphate (BCIP). Color reaction times were identical for both treat-
ment groups. For quantification, two to four color images per region per
mouse were analyzed using the mean intensity function in ImageJ (NIH).
All images were captured using the same light intensity and exposure
times. The mean intensity of the region of interest (minus mean intensity
of a selected background region) was averaged across images for each
mouse and each treatment group.
CFC Discrimination Learning
The conditioning chambers (183 183 30 cm) consisted of two clear Plexiglas
walls and ceiling, two metal walls, and a stainless steel grid floor (Coulbourn
Instruments, Whitehall, PA, USA). The conditioning chambers were placed in-
side a ventilated, sound-dampening isolation cubicles and lit by house lights
mounted on one wall (Coulbourn Instruments). FreezeFrame and FreezeView
software (Actimetrics,Wilmette, IL, USA) was used for recording and analyzing
freezing behavior, respectively. For the training context (designated A
throughout), the cubicle door was closed, the fan and house light were on, a
light cue was on, stainless-steel bars were exposed, silver wall panels were
used, and each conditioning chamber was cleaned with 70% ethanol between
each trial. Context B was a modified version of A by covering the stainless-steel bars with a solid floor covered with bedding, black wall panels were
used (covering 30% of total wall surface), 15 cm high curved green plastic in-
serts covered the bottom half of the walls, and the house fan and lights were
turned off. The cubicle door was left ajar, and white noise was delivered
through built-in speakers for the duration of the testing. The bedding was
changed between trials. Context C consisted of a disposable 2.4 Lwhite paper
bucket placed out of the cubicle in the same experimental room as contexts A
and B.
The CFC protocol consisted in a single 2 s footshock of 0.7 mA which was
delivered 180 s after placement of the mouse in the training context A. The
mouse was taken out 20 s after termination of the footshock. This procedure
was repeated for 3 days (24 hr apart). On day 4, 50% of the animals were first
tested in context A or B in the morning and context B or A in the afternoon. In
some instances, animals were also tested in context C, which took place after
both exposures to contexts A and B. No footshocks were delivered during the
test sessions. Mice were allowed to rest for 1–2 hr between tests. Freezing
behavior over the initial 180 s was used to assess discrimination between
both contexts. The discrimination ratio was calculated as (freezing in training
context  freezing in similar context)/(freezing in training context + freezing
in similar context).
Immunohistochemistry
Mice were anesthetized with ketamine and xylazine (100 mg/kg and 15 mg/kg,
intraperitoneal [i.p.]; Patterson Veterinary Supply, Devens, MA, USA) and
transcardially perfused with DEPC-treated PBS (10 mM PBS [pH 7.5]) at 4C,
followed by 4% PFA in DEPC-treated PBS at 4C. Brains were postfixed over-
night in the same solution at 4C, then cryoprotected in DEPC-treated PBS
sucrose (30%w/v) and stored at 4C before freezing in optimal cutting temper-
ature (OCT) on dry ice. Coronal serial sections (35 mm) were obtained using a
Leica cryostat in six matched sets. Sections were stored in PBS with 0.01% so-
dium azide at 4C. On day 1, free-floating sections were rinsed three times for
10 min in PBS, followed by a permeabilization step 15 min in 0.2% Triton
X-100 in PBS. The sections were rinsed another three times for 10 min in PBS
and 2 hr with a blocking buffer (10% w/v natural donkey serum [NDS]). After
three rinses in PBS, incubation with primary antibodies rabbit anti-GFP (Life
Technologies A11122, 1:500 [Antibodyregistry.org: AB_221569]) was carried
out with shaking at 4C overnight. On day 2, sections were rinsed three
times for 10 min in PBS and incubated for 90 min with a donkey anti-rabbit
fluorescein isothiocyanate (FITC)-coupled secondary antibody (1:500; Jackson
ImmunoResearch). Sections were rinsed three times for 10 min in PBS before
mounting in PBS and coverslipped with Fluoromount.
Image Analysis of Dendritic Spines
Quantification of dendritic spines was conducted as previously described
(McAvoy et al., 2016). Specifically, confocal z stack images were acquired
using a Nikon A1R Si confocal laser, a TiE inverted research microscope,
and NIS Elements software. Imaging was performed using a 603 objective,
plus 1.53 optical zoom and 63 digital zoom. For spine imaging, confocal
2.1 mM z stacks (2,048 resolution) with 0.3 mM step size were taken centered
on dendritic segment. Z stacks were flattened using the maximum intensity
projection, and flattened images were quantified using ImageJ. For spine
density, spines were counted manually for at least 80 mM of dendritic length
per region per mouse. The Edge fitter plugin (www.ghoshlab.org) was used
to measure head diameter (at the widest point of the spine head), while
length was measured manually from dendrite to the furthest point of the
spine head. More than 150 spines were analyzed per region per mouse to
calculate spine size distribution. In DG, images were obtained in the outer
molecular layer (defined as the third of the molecular layer furthest from
the granule cell layer). In CA1, images were obtained in the stratum radiatum,
which was defined as the two-thirds of the dendritic tree ventral to the pyra-




Brain tissue was obtained from the Brain Collection of the New York State Psy-
chiatric Institute at Columbia University, which includes brain samples from the
Republic of Macedonia. Brain tissue collection was conducted with institu-
tional review board (IRB) approval and consent obtained from all informants.Cell Reports 23, 3183–3196, June 12, 2018 3193
Subject Selection and Matching Procedure
All subjects are deceased. Our IRB has determined that this postmortem work
is not human subjects research. The only involvement of live individuals is as
informants for psychological autopsy interviews. Subjects were diagnosed us-
ing our validated psychological autopsy for DSM axis I and II diagnoses (Kelly
and Mann, 1996). History of lifetime psychiatric disorders and recent medica-
tion records were obtained. Clinical evaluation included global functioning as
measured using the Global Assessment Scale (GAS; score range 0–100, with
1–10 indicating danger of harming self or others, inability to maintain personal
hygiene, or serious suicide attempt, and 91–100 indicating no problems, supe-
rior functioning in several areas, or admired by others because of positive qual-
ities) (Endicott et al., 1976), as per DSM IV axis V; recent (over the past 2 month
period) life event-associated stress (related to primary support group, social
environment, education, occupation, housing, finances, health, legal, or other
psychosocial and environmental factors), quantified using St. Paul-Ramsey
Life Experience Scale (SPRS) total score and DSM-IV axis IV severity (score
range 1–7: none, minimal, mild, moderate, severe, extreme, and catastrophic)
(Roy et al., 1986); documentation of age at MDD onset; and number of major
depressive episodes (MDEs) lifetime.
We studied 24 subjects (Table S1): age- and sex-matched individuals with
no axis I or axis II cluster B personality disorder and death not by suicide (con-
trols) andMDD cases (n = 12 each), with six women andmen in each group. All
subjects died by sudden death, and we limited postmortem interval (PMI) to
24 hr. We screened brain tissue for low pH, excluding tissue that had been
damaged and showed low pH, and we controlled for PMI because it affects
brain proteins and mRNA (Lewis, 2002; Li et al., 2003).
Exclusion criteria were positive toxicology for psychoactive drugs or
alcohol, alcoholism-associated liver changes, suicide attempt history, intellec-
tual disability, AIDS, chronic illness, positive neuropathology, undetermined
death, resuscitation with prolonged (>10 min) hypoxia, received prescription
of psychotropic medications in the 3 months prior to death, and long agonal
states and chronic diseases. The presence of diseases affecting the brain
was excluded using clinical data, psychological autopsy interviews, and
neuropathological exams. Neuropathology excluded microvascular disease,
including white matter lacunae.
Brain Tissue Processing
At brain collection, 2-cm-thick coronal blocks of the right hemisphere were
flash-frozen in liquid freon (20C) and stored at 80C. Tissue samples
were fixed in formalin for neuropathological examination. Brain pH determina-
tion (Harrison et al., 1995) and toxicology were performed on cerebellar sam-
ples and blood. More than 30 drugs were screened for and quantified,
including amphetamine, cocaine, fluoxetine, sertraline, paroxetine, fluvox-
amine, amitriptyline, nortriptyline, imipramine, citalopram, chlorimipramine,
diazepam, alprazolam, buspirone, methadone, olanzapine, clozapine, and
haloperidol.
The hippocampal formation was dissected from frozen coronal blocks, fixed
in 4% PFA at 4C, cryoprotected in 30% sucrose, sectioned at 50 mm on a
sliding microtome (Microm HM440E), and stored in 40-well boxes at 20C
in cryoprotectant (30% ethylene glycol in 0.1 M PBS). One section every
500 mm was set aside for Nissl staining during the sectioning procedure.
Nissl-stained sections were later used for anatomical alignment along the
DG rostro-caudal axis of sections processed for ISH.
ISH in Human Tissue
In order to quantify the concentration of KLF9 mRNA in the anterior human
DG, we performed an ISH assay on three anterior hippocampus sections,
using an 35S-radiolabeled probe (200 bp: Nt 185-395 Homo sapiens Klf9,
mRNA [cDNA clone MGC:97030 IMAGE:7262239], complete cds Sequence
ID: BC069431.1), directed to KLF9 mRNA. The probe was labeled using
10 mCi/mL of cytidine 50 (a-thio) [35S] (PerkinElmer) and T3 polymerase and
then incubated at 37C for 90 min. Next, we added RQ1 RNase-Free DNase
and incubated at 37C for 30 min. Immediately after digesting the DNA
template, the RNA probe was purified using RNeasy Kit (QIAGEN, Hilden,
Germany), as directed by the manufacturer.
To prepare the brain tissue for hybridization with the probe described above,
50-mm-thick coronal sections of PFA-fixed hippocampus were washed in
0.05 M phosphate (pH 7.4) five times, 20 min each, in an orbital shaker at
60 rpm. The brain sections were then mounted on gelatin-coated microscope3194 Cell Reports 23, 3183–3196, June 12, 2018slide glasses and desiccated for 3 hr. The tissue was then hydrated in 1:10
diluted Dulbecco’s PBS for 5 min and then incubated in a solution of
0.15 M sodium chloride, 0.1 M triethanolamine, 50 mM hydrochloric acid,
and 25 mM acetic anhydride for 10 min. Then, the tissue was incubated in
2 3 SDS (0.3 M sodium chloride, 30 mM sodium citrate) for 1 min, followed
by increasing concentrations of ethanol, followed by 10 min in chloroform
and 1 min in 100% ethanol and then 95% ethanol.
To hybridize the probe with the tissue, the slides were dried for 1 min and
then hybridized with 100 mL of hybridization solution containing 1 3 106 dpm
of theKLF9 probe per slide, covered with a coverslip and placed in humidifying
chamber, at 55C for 18 hr. The probe was thenwashed off the tissue using the
following procedure: (1) 4 3 SSC containing 0.07 M 2-mercaptoethanol for
15 min; (2) 43 SSC for 15 min; (3) (1:1) formamide: buffer (0.6 M sodium chlo-
ride, 0.04 M Tris base, 0.01 mM hydrochloric acid, and 1 mM EDTA) for 20 min
at 55C; the probe was then digested in 10 mg/mL RNase A for 30 min at
37C; (4) serial washes of decreasing concentrations from 2 3 to 0.5 3
SSC; (5) 0.13 SSC for 30 min at 55C; and (6) 0.13 SSC at room temperature
and last in 60% ethanol and 0.33% ammonium acetate.
Then, glass slides with the mounted hybridized tissue were dried and
exposed in the dark to a BioMax MR film (Carestream Kodak) for 10 days,
accompanied by standards of radioactivity, ranging from 0 to 2.15 nCi/mg
(14C catalog number ARC 146A; American Radiolabeled Chemicals).
The film was then developed using developer and fixer solutions (Care-
stream Kodak), and the autoradiographs of the tissue and the standards
were digitized using an Epson Expression 11000XL scanner at 3,200 dots
per inch (dpi).
Densitometry Analysis of KLF9 mRNA Content in DG
The concentration of KLF9mRNAwas quantified using Densita software (MBF
Bioscience,Willinston, VT, USA), as explained below. Densita software calcu-
lated the relative optical density (ROD) of the scanned autoradiograms of
radioactivity standards and created a graph of the concentration of each stan-
dard, in nanocuries per milligram, versus their relative optical density. We
calculated the relative optical density produced by the hybridization of the
KLF9 35S probe in hippocampal DG in digitized autoradiographs. We first
contoured the DG area using sections that had been stained for Nissl as
anatomical reference. Contours were then superimposed on the digitized
ISH autoradiographs, and the relative optical density of each DG contour
was determined using Densita. The relative optical densities were entered
into the standard curve to obtain the correspondent radioactivity concentra-
tion. Densita software corrected the KLF9 concentrations using the specific
activity of the radioisotope in the probe and the rate decay of the radioisotope.
Finally, the concentration of mRNAKLF9 in the contour of DG areas was calcu-
lated on three sections of the anterior portion of the hippocampus as average
concentration in nanocuries per milligram of tissue. The final DG relative opti-
cal density was background-corrected, subtracting the background signal in
the tissue white matter and on the slide (outside the section) from the relative
optical density of the DG in the same section.
Data Availability
All relevant data are available from the authors.
Statistical Analysis
All analyses were performed by an investigator blinded to treatment and/or ge-
notype using SPSS version 24 for Mac and GraphPad Prism version 7. ISH
data (mean ± SEM) were analyzed using unpaired two-tailed Student’s t test
or one-way ANOVA followed by Tukey’s multiple-comparisons post hoc
test. p values were corrected for multiple comparison to q values to control
for false discovery rate (FDR) (desired FDR [Q] = 5%) (Benjamini et al.,
2006). Behavioral and morphological data were analyzed using mixed-factor
two-way ANOVA (with or without repeated measures over time) followed by
Tukey’s multiple-comparisons test when appropriate (only if interaction p <
0.05). Linear regression was used to test correlations between recent stressful
life event severity score and KLF9 mRNA density in human tissue. Univariate
ANOVA was used to test KLF9 mRNA density differences in controls and
MDD, men and women, using age, St. Paul-Ramsey Life Experience Scale
score, PMI, pH, and age as covariates. In any case, significance was set at
p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and one table and can be
found with this article online at https://doi.org/10.1016/j.celrep.2018.05.040.
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